Download PSA Shared Care - The Castle Practice

PSA Shared Care
Jim Wood
Background


A significant number of men with
prostate cancer (CaP) are receiving
regular hospital follow up (outpatient visits), who might be more
efficiently managed in primary care.
The shared care (SC) scheme is
currently being piloted in Mid-Devon.
Aims of the project



To improve quality of care for men with
prostate cancer and/or raised PSA
To reduce the frequency of hospital follow
up visits for men with prostate
cancer/raised PSA.
To provide an agreed framework for the
management of these men between
primary and secondary care.
Eligibility



Men with stable disease on hormone
therapy or no active treatment (watchful
waiting).
Men who have previously received radical
treatment i.e. with curative intent (usually
radical prostatectomy or radiotherapy),
who are now on routine monitoring with
stable PSA.
Men with a raised serum PSA who have
not been diagnosed with prostate cancer,
but require regular PSA monitoring.
Aims of the pilot










Assess the impact of introducing the SC scheme in
Mid-Devon prior to more widespread use
Identify:
1. total number of CaP patients in Mid-Devon
2. number receiving shared care
3. number receiving hospital follow up alone
4. number receiving GP care alone
5. number receiving no prostate cancer follow up
For all these pre and post the project.
Establish how many men can be managed by SC; if
this is a significant number this will allow us to roll out
the initiative across the region.
The aim is to complete the project in Mid-Devon by
end March 2011
Figures so far




From data we have had back so far 401
patients identified.
The urology team have analysed 95 of
these so far and of those 55 (58%) would
be appropriate for shared care.
Mr Crundwell estimates these average 3
follow up appointments per patient per
year.
Extrapolating this for patients identified so
far (assuming 58% will be eligible for
shared care) – would save 696 outpatient
appointments per year.
Next steps



Contact practices directly that we do
not yet appear to have had results
from.
Acting as liaison between Urologists
and practices.
Report back on the outcome of the
Project via the MDCF.
Any questions?